Dr. Peggy Manders, Radboud Biobank, will be the state-of-the-art speaker leading the panel session ‘Securing the future of biobanks: New collaboration models for sustainability’. We have profiled her biography and abstract here.  Dr. Peggy Manders Dr. Peggy Manders is trained in epidemiology (biomedical sciences) and received a PhD on biomarker research in breast cancer. She has…

Dr. Peggy Manders, Radboud Biobank, will be the state-of-the-art speaker leading the panel session ‘Empowering the next generation: Education and training in biobanking’. We have profiled her biography and abstract here. Dr. Peggy Manders Dr. Peggy Manders is trained in epidemiology (biomedical sciences) and received a PhD on biomarker research in breast cancer. She has been…

Prof. Dr. Peter Hufnagl, Charité, will be the state-of-the-art speaker leading the panel session ‘Biobanks in big data research and AI’. We have profiled his biography and abstract here. Prof. Dr. Peter Hufnagl Prof. Dr. Peter Hufnagl studied mathematics and statistics at the Academy of Mining, Freiberg. During his scientific career, Prof. Dr. Hufnagl has dealt…

The Ethics Café is an established event of the Europe Biobank Week conferences, where all stakeholders come together in an informal setting to voice their thoughts on the role that ethics frameworks play in the context of biomedical innovation. Grab your coffee and join us for a interactive discussion. This session will be chaired by:…

Sandra Nanyonga, Université Côte d’Azur, will be the state-of-the-art speaker leading the panel session ‘Organisational Profiles’. We have profiled her biography and abstract here. Sandra Nanyonga Sandra Nanyonga is a research scientist specialising in biobanking with extensive experience in managing daily biobank operations and ensuring compliance with quality, regulatory, ethical, and legal standards. Her training across biobanks…

A new collaborative model for the sustainability of biobanks emphasises partnerships between academic institutions, healthcare organisations, government agencies and private sector stakeholders. This session will explore how by pooling resources, knowledge and technology, these entities can improve the quality and accessibility of biological samples that are critical to disease research, treatments and public health initiatives…

Dr. Dominic Bläsing, Helmholtz Institute for One Health, will be the state-of-the-art speaker leading the panel session ‘One Health: Non-human biobanking’. We have profiled his biography and abstract here. Dr. Dominic Bläsing Dominic Bläsing holds a PhD in applied ergonomics and brings extensive experience in psychological research across experimental, field, and epidemiological settings. He currently serves…

Monika Valjan, MA, Biobank Graz, will be the state-of-the-art speaker leading the panel session ‘Green biobanking: Paving the path to sustainable practices’. We have profiled her biography and abstract here. Monika Valjan, MA Monika Valjan, MA, holds a degree in media studies and has been the managing director of Biobank Graz since 2021. In 2017, she…

Dr. Tilman Pfeffer, DZIF Tissue Bank, will be the state-of-the-art speaker leading the panel session ‘Clinical biobanks: Bridging research and patient care’. We have profiled his biography and abstract here.  Dr. Tilman Pfeffer After his PhD study in the late effects of diabetes mellitus with a focus on diabetic nephropathy, Dr. Tilman Pfeffer started at the…

From wildlife conservation via plant diversity and agricultural research to environment monitoring – non-human biobanks play a vital role in preserving genetic diversity and advancing scientific understanding across disciplines. In this session, we will explore the unique challenges and opportunities for non-human biobanks by showcasing their impact towards One Health with a state-of-the-art talk from…

Dr. Ronny Baber from University Leipzig will be the state-of-the-art speaker leading the panel session: ‘Implementing and securing quality control in biobanking’. We have profiled his biography and abstract here.  Dr. Ronny Baber Dr. Ronny Baber works in the Institute of Laboratory Medicine, Clinical Chemistry, and Molecular Diagnostics at the University Hospital Leipzig. He is the…

This session will highlight the critical biobank resources in multi-omics research, their challenges in sample collection and the integration of the requirements of different ‘omics’ fields, such as genomics, transcriptomics, proteomics and metabolomics into the operational biobank routine, clinical applications and IVDR. This session will be chaired by: Dr. Ronny Baber Dr. Ronny Baber works…

This session opens the stage for any special samples, sampling methods or processing techniques that can facilitate innovative research needs and strategies. The focus will be broad and include, among others, novel or rarely collected materials as well as home-based data collection and sampling. This session will be chaired by: Dr. Anna Beskow Dr. Anna…

Dr. Mindaugas Morkūnas from the Vilnius Santaros Klinikos Biobank will be the state-of-the-art speaker leading the panel session: ‘Dataflows in healthcare integrated biobanking’. We have profiled his biography and abstract here.  Dr. Mindaugas Morkūnas Dr. Mindaugas Morkūnas is a senior researcher and bioinformatician at Vilnius Santaros Klinikos Biobank. With over 25 years experience in biotechnology and…

This session explores the transformative impact of new EU regulations on biobanking and their alignment with national laws, focusing on ethical, legal and societal implications (ELSI). Attendees will gain insight into recent EU directives, their implications for consent, data governance and cross-border collaboration, as well as strategies for harmonising national regulations with EU frameworks. This…

Prof. Walter Ricciardi, Cancer Mission Board Chair (EC) and Chair of the BBMRI-ERIC Scientific and Ethical Advisory Board, will give a keynote on the critical need for courageous leadership in science and health in an era marked by unprecedented global challenges. Read more about Prof. Ricciardi here. This post introduces the session chairs: Prof. Marialuisa…

Biobanking would not be possible without taking into account all the ethical, social and legal implications that are inextricably linked to biobanking activities. In this session, we will present the current state of affairs in ELSI as well as how the impetus for innovation and biomedical knowledge production can be enhanced by implementing an embedded…

AI promises integrated solutions to analysing images (e.g. whole slide and/or radiology images), multi-omics data, and clinical information but also faces challenges such as the increasing complexity of managing and integrating data from different sources and the need to efficiently use machine learning-based algorithms to process and understand big data. This session will discuss challenges…

This session will discuss the key role of clinical biobanks in linking research with patient care in the era of personalised medicine. It will address the challenges biobanks face, including ethical concerns and data management, and present innovative solutions. Experts will discuss successful case studies demonstrating how biobanks are improving patient engagement and streamlining research…

Prof. Dr. Milani from the University of Tartu will give a keynote discussing MyGenome, an online portal providing over 100,000 participants with personalised genetic risk reports and interactive health insights. The keynote will provide an overview of the portal and the feedback received from participants. Read more about Prof. Dr. Milani here. This post introduces the…